Mitochondria Disease and Market Shifts

This chapter explores a pioneering treatment for mitochondria disease involving genetic material transfer, enabling births without the inherited condition. It also discusses the failed acquisition bid by Couchtard for Seven and I, highlighting the complexities of foreign investments in Japan. Additionally, the chapter covers recent diplomatic efforts by the UK to strengthen European relations amid global tensions and the implications of high-value fossil sales on paleontological research.